PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 59 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $241,000 | -64.5% | 229,792 | 0.0% | 0.00% | – |
| Q4 2015 | $678,000 | -6.0% | 229,792 | +0.8% | 0.00% | – |
| Q3 2015 | $721,000 | -47.4% | 228,072 | -1.6% | 0.00% | -100.0% |
| Q2 2015 | $1,372,000 | -39.6% | 231,780 | +9.1% | 0.00% | 0.0% |
| Q1 2015 | $2,270,000 | +10.5% | 212,352 | -3.0% | 0.00% | 0.0% |
| Q4 2014 | $2,055,000 | +22.2% | 218,821 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,681,000 | -11.6% | 218,821 | +3.3% | 0.00% | 0.0% |
| Q2 2014 | $1,902,000 | +204.8% | 211,843 | +81.7% | 0.00% | – |
| Q1 2014 | $624,000 | +112.2% | 116,591 | 0.0% | 0.00% | – |
| Q4 2013 | $294,000 | -4.2% | 116,591 | +3.7% | 0.00% | – |
| Q3 2013 | $307,000 | -24.4% | 112,406 | -0.1% | 0.00% | – |
| Q2 2013 | $406,000 | – | 112,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
| Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
| Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
| Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
| Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
| WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
| SEARLE & CO. | 172,500 | $500,000 | 0.48% |
| Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
| KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |